Packard Q4 Revenues up 7 Percent | GenomeWeb

NEW YORK, Feb 8 - Packard BioScience said Thursday its fourth quarter revenues increased 7 percent to $49.9 million, as sales of instruments, chemicals, and supplies helped to offset a drop in service revenues.

The Meriden, Conn.-based company said that foreign currency fluctuations also weighed on revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.